These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10370935)

  • 41. [Spastic syndrome. More mobile again after stroke].
    MMW Fortschr Med; 2001 Mar; 143(10):46. PubMed ID: 11268740
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacological risks following stroke.
    Smith J
    Phys Ther; 2005 Jan; 85(1):81-2. PubMed ID: 15623365
    [No Abstract]   [Full Text] [Related]  

  • 43. Baclofen in the treatment of intractable hiccups.
    Patial RK
    J Assoc Physicians India; 2002 Oct; 50():1312-3. PubMed ID: 12568219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 45. [Intrathecal baclofen. Experimental and pharmacokinetic studies].
    Sallerin B; Lazorthes Y
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):271-5. PubMed ID: 12746702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of spasticity in paraplegia. A new muscle relaxant Ciba 34'647-Ba].
    Henning K; Edelmann P
    Med Welt; 1972 Feb; 23(6):203-5. PubMed ID: 5060489
    [No Abstract]   [Full Text] [Related]  

  • 47. [Baclofen dose in a screening test and in a baclofen pump filling--is there any differences].
    Grzegorzewski P; Kawecki Z; Swierczyńska A; Fafara A; Kwiatkowski S
    Przegl Lek; 2007; 64 Suppl 2():8-12. PubMed ID: 17953271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Centrally acting skeletal-muscle relaxants.
    Domino EF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):369-73. PubMed ID: 4850933
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term tolerability of Lioresal.
    Rigby F
    Postgrad Med J; 1972 Oct; 48():Suppl 5:28-9. PubMed ID: 4668366
    [No Abstract]   [Full Text] [Related]  

  • 52. [Tactics of Arduan administration].
    Darbinian TM; Sud'in VI; Lagutina AI
    Anesteziol Reanimatol; 1982; (4):49-53. PubMed ID: 6291434
    [No Abstract]   [Full Text] [Related]  

  • 53. The rational use of muscle relaxants in rehabilitation medicine.
    Györy AN
    Drugs; 1980 Oct; 20(4):309-18. PubMed ID: 7418628
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence basis for treatment of spasticity.
    Dawson DM
    Curr Neurol Neurosci Rep; 2001 Nov; 1(6):501-6. PubMed ID: 11898562
    [No Abstract]   [Full Text] [Related]  

  • 55. [The administration of midocalm in the treatment of vertebrogenic algesic syndromes].
    Avakian GN; Chukanova EI; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):26-31. PubMed ID: 10849963
    [No Abstract]   [Full Text] [Related]  

  • 56. [Myorelaxants in ophthalmology].
    Bobrova GV
    Vestn Oftalmol; 1987; 103(2):69-73. PubMed ID: 3299995
    [No Abstract]   [Full Text] [Related]  

  • 57. [New knowledge of spasticity and its treatment].
    Lorentzen J; Willerslev-Olsen M; Crone C; Sinkjær T; Nielsen JB
    Ugeskr Laeger; 2012 Feb; 174(9):569-73. PubMed ID: 22369906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of oral skeletal muscle relaxants for the craniomandibular disorder (CMD) practitioner.
    Stanko JR
    Cranio; 1990 Jul; 8(3):234-43. PubMed ID: 2083431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adductor muscle spasticity.
    Ghai A; Garg N; Wadhera R
    Acta Anaesthesiol Scand; 2011 Feb; 55(2):250; author reply 250-1. PubMed ID: 21226870
    [No Abstract]   [Full Text] [Related]  

  • 60. [Electromyographic control of the effects of a muscle relaxant: LCB 29 in pyramidal hypertonia].
    Cadilhac J; Daprès G
    Rev Electroencephalogr Neurophysiol Clin; 1972; 2(2):153-8. PubMed ID: 4681591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.